BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35234697)

  • 1. Helicobacter pylori may participate in the development of inflammatory bowel disease by modulating the intestinal microbiota.
    Bai X; Jiang L; Ruan G; Liu T; Yang H
    Chin Med J (Engl); 2022 Mar; 135(6):634-638. PubMed ID: 35234697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal microbiome and
    Sitkin S; Lazebnik L; Avalueva E; Kononova S; Vakhitov T
    World J Gastroenterol; 2022 Feb; 28(7):766-774. PubMed ID: 35317277
    [No Abstract]   [Full Text] [Related]  

  • 3. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection and inflammatory bowel disease: is there a link?
    Papamichael K; Konstantopoulos P; Mantzaris GJ
    World J Gastroenterol; 2014 Jun; 20(21):6374-85. PubMed ID: 24914359
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yang L; Zhang J; Xu J; Wei X; Yang J; Liu Y; Li H; Zhao C; Wang Y; Zhang L; Gai Z
    Front Cell Infect Microbiol; 2019; 9():375. PubMed ID: 31781514
    [No Abstract]   [Full Text] [Related]  

  • 6. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
    Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Gut Microbiota and
    Gao JJ; Zhang Y; Gerhard M; Mejias-Luque R; Zhang L; Vieth M; Ma JL; Bajbouj M; Suchanek S; Liu WD; Ulm K; Quante M; Li ZX; Zhou T; Schmid R; Classen M; Li WQ; You WC; Pan KF
    Front Cell Infect Microbiol; 2018; 8():202. PubMed ID: 29971220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection is associated with an altered gastric microbiota in children.
    Brawner KM; Kumar R; Serrano CA; Ptacek T; Lefkowitz E; Morrow CD; Zhi D; Kyanam-Kabir-Baig KR; Smythies LE; Harris PR; Smith PD
    Mucosal Immunol; 2017 Sep; 10(5):1169-1177. PubMed ID: 28120843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicide journey of H. pylori through gastric carcinogenesis: the role of non-H. pylori microbiome and potential consequences for clinical practice.
    de Assumpção PP; Araújo TMT; de Assumpção PB; Barra WF; Khayat AS; Assumpção CB; Ishak G; Nunes DN; Dias-Neto E; Coelho LGV
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1591-1597. PubMed ID: 31114971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance of Gastrointestinal Microbiota in the Pathogenesis of Helicobacter pylori-Associated Diseases.
    He C; Yang Z; Lu N
    Helicobacter; 2016 Oct; 21(5):337-48. PubMed ID: 26876927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis.
    Bakhti SZ; Latifi-Navid S
    BMC Microbiol; 2021 Sep; 21(1):258. PubMed ID: 34556055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Plasmon-Activated Water Increases
    Chang CC; Liu CY; Su IC; Lee YJ; Yeh HJ; Chen WC; Yu CJ; Kao WY; Liu YC; Huang CJ
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota.
    Ferreira RM; Pereira-Marques J; Pinto-Ribeiro I; Costa JL; Carneiro F; Machado JC; Figueiredo C
    Gut; 2018 Feb; 67(2):226-236. PubMed ID: 29102920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of intestinal microbiota and microbiota-based treatments in IBD.
    Li Q; Zhou S; Wang Y; Cong J
    Arch Microbiol; 2022 Jul; 204(7):442. PubMed ID: 35776212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of
    Guo Y; Zhang Y; Gerhard M; Gao JJ; Mejias-Luque R; Zhang L; Vieth M; Ma JL; Bajbouj M; Suchanek S; Liu WD; Ulm K; Quante M; Li ZX; Zhou T; Schmid R; Classen M; Li WQ; You WC; Pan KF
    Gut; 2020 Sep; 69(9):1598-1607. PubMed ID: 31857433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Bowel Diseases and Gut Microbiota.
    Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of
    Zheng W; Miao J; Luo L; Long G; Chen B; Shu X; Gu W; Peng K; Li F; Zhao H; Botchway BOA; Fang M; Jiang M
    Front Immunol; 2021; 12():625586. PubMed ID: 33841407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between
    Chen CC; Liou JM; Lee YC; Hong TC; El-Omar EM; Wu MS
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33938378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.